Eli Lilly says some Medicare plans may exceed $50 cap for weight-loss drugs

$50 per month cap: Eli Lilly said a small number of basic Medicare drug plans may not follow the $50/month out-of-pocket cap for its weight-loss drugs under the Medicare agency's coverage model. That could raise costs for affected beneficiaries and modestly limit uptake of Lilly’s drugs among those enrollees. Impact appears limited given the 'small number' qualifier, but it poses a minor revenue and reputational risk and could invite further regulatory scrutiny.

Analysis

$50 per month cap: Eli Lilly said a small number of basic Medicare drug plans may not follow the $50/month out-of-pocket cap for its weight-loss drugs under the Medicare agency's coverage model. That could raise costs for affected beneficiaries and modestly limit uptake of Lilly’s drugs among those enrollees. Impact appears limited given the 'small number' qualifier, but it poses a minor revenue and reputational risk and could invite further regulatory scrutiny.